Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2019
Price : $35 *
At a glance
- Drugs L-Acetylleucine (Primary)
- Indications Ataxia telangiectasia
- Focus Therapeutic Use
- Sponsors IntraBio
- 18 Nov 2019 Planned primary completion date changed from 1 May 2020 to 1 Jun 2020.
- 18 Nov 2019 Status changed from not yet recruiting to recruiting.
- 28 Oct 2019 Planned End Date changed from 1 Jun 2020 to 1 Jul 2020.